Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by 1ottrunneron Jun 30, 2021 12:33pm
84 Views
Post# 33473592

RE:RE:RE:RE:RE:RE:RE:Merck knows the importance of RVV's Bucillamine

RE:RE:RE:RE:RE:RE:RE:Merck knows the importance of RVV's Bucillamine

Show some fact which ties RVV to Merck as you stated.

You're a fraud.  You don't even understand the basics of the markets.  You come here and post without basic knowledge in the hopes to suck in other morons?

Institutions do NOT invest in penny stocks.  
Merck has no ties to RVV at this time.
Bucillamine is not going to get EUA in India this week.

Possibilities:  We get a trial update this week.  If history repeats itself MF will drop good news when Canuck markets are closed, screwing his countrymen out of the chance to play highs.

Outside of that, and the above has a 50/50 chance of being positive (I'm being kind), there is ZERO going on here.

Realize that MF and his board are all piggy backing each others tickers at investor expense.  Do some DD on that.

TheTerminator1 wrote: Is that right....Your behind on your DD or playing the stupid game
 

1ottrunner wrote: Institutional buyers will have ZERO to do with a penny stock.

You do know this, right?

I'm not telling you something you don't know, correct?  


TheTerminator1 wrote: I will let US Institutional Buyers do all the talking if you are smart enough to know what i mean!!!

1ottrunner wrote:

You made the statement.  You have to prove it.  You can't ask me to prove your BS wrong.

Do you think posting idiotic BS here helps the SP?  Are you dumb enough to believe that you have some control over the market from Stockhouse?

 

 

TheTerminator1 wrote: Prove me wrong
 

 

1ottrunner wrote:

Merck does?  BS!  Offer some realiable DD on this.

Why post rediculous garbage?

 

TheTerminator1 wrote: Lots of good new news to come for RVV shareholders

Stay connected

 

 


 

 

 

 




<< Previous
Bullboard Posts
Next >>